Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis

Go back to Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
Capital Gold (NASDAQ: CGC) Delayed: 0.97 --0 (-0%)
Previous Close $0.97    52 Week High $6.57 
Open $0.98    52 Week Low $2.30 
Day High $0.98    P/E 3.46 
Day Low $0.96    EPS $0.28 
Volume 1,902,152       

(NYSE: WEED) Delayed: 22.67 +0.48 (2.16%)
Previous Close $22.19    52 Week High
Open $22.10    52 Week Low
Day High $22.67    P/E N/A 
Day Low $22.10    EPS
Volume 19,508